Recent Posts

UCI Startup Company jCyte Partners with Santen Pharmaceutical June 4, 2020 - UCI Beall Applied Innovation June 4, 2020 By Ethan Perez UCI company jCyte, Inc. has formalized an exclusive licensing contract with Japanese pharmaceutical company Santen Pharmaceutical. jCyte, founded by Dr. Henry Klassen and Dr. Jing Yang of UC Irvine’s School… Read More >
Santen Inks $252M License to jCyte Ocular Cell Therapy May 9, 2020 - BioWorld   Santen inks $252M license to Jcyte ocular cell therapy  May 8, 2020 By Michael Fitzhugh Keen to address a rare vision-limiting disorder endured by nearly 1.9 million people globally, ophthalmology specialist Santen Pharmaceutical… Read More >
jCyte Inc. Enters into Ex-US Licensing and Commercialization Agreement for jCell Therapy with Global Ophthalmology Leader Santen Pharmaceutical May 8, 2020 - jCyte Inc. Enters into Ex-US Licensing and Commercialization Agreement for jCell Therapy with Global Ophthalmology Leader Santen Pharmaceutical jCyte to receive up to $252 million, inclusive of $50 million in upfront cash, $12 million in… Read More >